A generation that thinks and feels differently Gen Z is the first generation to enter medicine as digital natives, but their ...

Lilly has announced plans to build a $6bn facility in Alabama in the US for the manufacture of active pharmaceutical ...

Kymera Therapeutics has announced positive results from its trial of KT-621 to treat patients with moderate to severe atopic ...

The US FDA has announced the launch of the Technology-Enabled Meaningful Patient Outcomes (TEMPO) for Digital Health Devices ...

Discover Jim Sage’s insights on leadership, industry challenges, and the transformative impact of data, technology, and ...

Our Nature Custom Media team recently took on an ambitious project: producing a video that spanned two continents, covered a ...

Eli Lilly has appointed Carolyn Bertozzi to its Board of Directors as a returning member, after she served on Lilly’s board ...

At ISPOR Europe in Glasgow, there were literal queues around the block for Tim Wright's HEOR Theater presentation 'MFN Pricing: More Fun to Navigate – A European Roadmap to Success,' with potentially ...

Pfizer has announced results from its phase 3 BASIS study of Hympavzi (marstacimab), demonstrating its success in reducing ...

Novo Nordisk has presented new findings from its phase 3 Evoke and Evoke+ trials on using semaglutide as part of Alzheimer’s ...

Exhibitions remain one of the most powerful ways for pharmaceutical and life sciences organisations to connect, educate and ...

OPEN Health has announced the appointment of Diala Habib as president of two of its practices, Promotional Medical Education and Patient Engagement.